SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p

SOX2 mediates cisplatin resistance in small‐cell lung cancer with downregulated expression of hsa‐miR‐340‐5p

Abstract Background This study is aimed to unravel the genetic factors associated with microRNA (miRNA) expression in regulating sex‐determining region Y‐box 2 (SOX2)‐mediated cisplatin resistance in small‐cell lung cancer (SCLC). Methods The relevance of SOX2 expression in SCLC was analyzed in a pa...

Full description

Bibliographic Details
Main Authors:	Fei Cui, Zhe‐xue Hao, Jin Li, Ya‐lei Zhang, Xu‐kai Li, Jian‐xing He
Format:	Article
Language:	English
Published:	Wiley 2020-05-01
Series:	Molecular Genetics & Genomic Medicine
Subjects:	cisplatin resistance miRNA small‐cell lung cancer SOX2
Online Access:	https://doi.org/10.1002/mgg3.1195

Similar Items

MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
by: Pierre-Antoine Bissey, et al.
Published: (2020-06-01)

miR‐129‐2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4
by: Weizheng Zhou, et al.
Published: (2022-04-01)

miR-208a in Cardiac Hypertrophy and Remodeling
by: Xing-Huai Huang, et al.
Published: (2021-12-01)

Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis
by: Hongya Xie, et al.
Published: (2022-12-01)

miRNA-214-5p inhibits prostate cancer cell proliferation by targeting SOX4
by: Guangchi Xu, et al.
Published: (2021-12-01)

MiR‐17‐3p inhibits osteoblast differentiation by downregulating Sox6 expression
by: Nan Chen, et al.
Published: (2020-11-01)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
by: Camile B. Lopes, et al.
Published: (2018-07-01)

miR-2053 inhibits the growth of ovarian cancer cells by downregulating SOX4
by: Huang Xin, et al.
Published: (2023-05-01)

miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Nadine De Godoy Torso, et al.
Published: (2023-11-01)

Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122
by: Rui Su, et al.
Published: (2017-11-01)

Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours
by: Jan Roška, et al.
Published: (2023-01-01)

The Effect of SLC2A3 Expression on Cisplatin Resistance of Colorectal Cancer Cells
by: Yan Li, et al.
Published: (2021-11-01)

Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine
by: Sheng Li, et al.
Published: (2023-12-01)

Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer
by: Bai Xue, et al.
Published: (2021-04-01)

Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429
by: Xiaofeng Wang, et al.
Published: (2022-03-01)

CD59 receptor targeted delivery of miRNA-1284 and cisplatin-loaded liposomes for effective therapeutic efficacy against cervical cancer cells
by: Li Wang, et al.
Published: (2020-03-01)

miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma
by: Põlajeva Jelena, et al.
Published: (2012-08-01)

Hsa-Mir-320c, Hsa-Mir-200c-3p, and Hsa-Mir-449c-5p as Potential Specific miRNA Biomarkers of COPD: A Pilot Study
by: Noemi Cerón-Pisa, et al.
Published: (2022-03-01)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
by: Sofía Elena Tesolato, et al.
Published: (2023-06-01)

The MRTF-A/miR-155/SOX1 pathway mediates gastric cancer migration and invasion
by: Libin Yin, et al.
Published: (2020-07-01)

WASF3 overexpression affects the expression of circular RNA hsa-circ-0100153, which promotes breast cancer progression by sponging hsa-miR-31, hsa-miR-767-3p, and hsa-miR-935
by: Majid Mokhtari, et al.
Published: (2023-12-01)

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
by: Linxiang Feng, et al.
Published: (2023-05-01)

MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer
by: Marienid Flores-Colón, et al.
Published: (2024-03-01)

Long non-coding RNA BLACAT1 expedites osteosarcoma cell proliferation, migration and invasion via up-regulating SOX12 through miR-608
by: Xiaotao Chen, et al.
Published: (2020-12-01)

XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma
by: Yuhui Wang, et al.
Published: (2020-03-01)

miR-6077 promotes cisplatin/pemetrexed resistance in lung adenocarcinoma via CDKN1A/cell cycle arrest and KEAP1/ferroptosis pathways
by: Guoshu Bi, et al.
Published: (2022-06-01)

LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2
by: Zhining Yang, et al.
Published: (2023-11-01)

hsa_circ_0008285 Facilitates the Progression of Cervical Cancer by Targeting miR-211-5p/SOX4 Axis
by: Bai Y, et al.
Published: (2020-05-01)

Circ_0075825 promotes gastric cancer progression via adsorbing miR-432-5p to modulate SOX9
by: He Li, et al.
Published: (2022-05-01)

Hsa-miR-557 Inhibits Osteosarcoma Growth Through Targeting KRAS
by: Zhi Qiao, et al.
Published: (2022-01-01)

Downregulation of hsa-miR-4328 and target gene prediction in Acute Promyelocytic Leukemia
by: Lupu Onda T., et al.
Published: (2022-07-01)

Downregulation of SOX2-OT Prevents Hepatocellular Carcinoma Progression Through miR-143-3p/MSI2
by: Hongfeng Zhao, et al.
Published: (2021-07-01)

Ssc-MiR-21-5p and Ssc-MiR-615 Regulates the Proliferation and Apoptosis of Leydig Cells by Targeting SOX5
by: Qi Tang, et al.
Published: (2022-07-01)

MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma
by: L. Song, et al.

The Effect of Placenta Growth Factor Knockdown on hsa-miR-22-3p, hsa-let-7b-3p, hsa-miR-451b, and hsa-mir-4290 Expressions in MKN-45- derived Gastric Cancer Stem-like Cells
by: Zohreh Salehi, et al.
Published: (2018-04-01)

Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy
by: Ye Tian, et al.
Published: (2018-06-01)

MiR-539-3p inhibited chondrogenic differentiation in human adipose stem cells by targeting Sox9
by: Feng Qin, et al.
Published: (2022-03-01)

Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
by: Yuzhu Di, et al.
Published: (2021-07-01)

Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression
by: Feng Liu, et al.
Published: (2021-12-01)